Pulmonary hypertension in heart failure epidemiology, right ventricular function, and survival

American Journal of Respiratory and Critical Care Medicine

Volumn 192, Issue 10, 2015, Pages 1234-1246

  Gerges, Mario ^a   Gerges, Christian ^a   Pistritto, Anna Maria ^b   Lang, Marie B ^a   Trip, Pia ^c   Jakowitsch, Johannes ^a   Binder, Thomas ^a   Lang, Irene M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF CATANIA   (Italy)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Heart failure; Hemodynamics; Pulmonary heart disease; Pulmonary hypertension

Indexed keywords

CREATININE;

ADULT; AGE; ARTERY COMPLIANCE; ARTICLE; ATRIAL FIBRILLATION; BODY MASS; CARDIAC PATIENT; CARDIOVASCULAR RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CREATININE CLEARANCE; DIASTOLIC HEART FAILURE; ECHOCARDIOGRAPHY; FEMALE; HEART AFTERLOAD; HEART CATHETERIZATION; HEART EJECTION FRACTION; HEART FAILURE; HEART INDEX; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEART RATE; HEART RIGHT ATRIUM PRESSURE; HEART RIGHT VENTRICLE FUNCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; LUNG WEDGE PRESSURE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEW YORK HEART ASSOCIATION CLASS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; SURVIVAL; SURVIVAL RATE; SYSTEMIC VASCULAR RESISTANCE; SYSTOLIC HEART FAILURE; TRICUSPID VALVE REGURGITATION; VALVULAR HEART DISEASE; VENOUS OXYGEN TENSION; AGED; ANALYSIS OF VARIANCE; AUSTRIA; COMORBIDITY; COMPLICATION; DEATH CERTIFICATE; DIAGNOSIS; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMICS; HYPERTENSION, PULMONARY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PREVALENCE; PROGNOSIS; PULMONARY HEART DISEASE; RISK ASSESSMENT; SEX RATIO; STATISTICAL MODEL;

AGED; ANALYSIS OF VARIANCE; AUSTRIA; COMORBIDITY; DEATH CERTIFICATES; FEMALE; HEART FAILURE; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY HEART DISEASE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION; SURVIVAL ANALYSIS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84949033971     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201503-0529OC     Document Type: Article

References (40)

1. Vachiéry JL, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V, De Marco T, Galiè N, Ghio S, Gibbs JS, et al. Pulmonary hypertension due to left heart diseases. J Am Coll Cardiol 2013;62: (25, Suppl) D100-D108.
2. Abramson SV, Burke JF, Kelly JJ Jr, Kitchen JG III, Dougherty MJ, Yih DF, McGeehin FC III, Shuck JW, Phiambolis TP. Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy. Ann Intern Med 1992;116: 888-895.
3. Aronson D, Eitan A, Dragu R, Burger AJ. Relationship between reactive pulmonary hypertension and mortality in patients with acute decompensated heart failure. Circ Heart Fail 2011;4: 644-650.
4. Ghio S, Gavazzi A, Campana C, Inserra C, Klersy C, Sebastiani R, Arbustini E, Recusani F, Tavazzi L. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol 2001;37: 183-188.
5. Meyer P, Filippatos GS, Ahmed MI, Iskandrian AE, Bittner V, Perry GJ, White M, Aban IB, Mujib M, Dell'Italia LJ, et al. Effects of right ventricular ejection fraction on outcomes in chronic systolic heart failure. Circulation 2010;121: 252-258.
6. Burke MA, Katz DH, Beussink L, Selvaraj S, Gupta DK, Fox J, Chakrabarti S, Sauer AJ, Rich JD, Freed BH, et al. Prognostic importance of pathophysiologic markers in patients with heart failure and preserved ejection fraction. Circ Heart Fail 2014;7: 288-299.
7. Melenovsky V, Hwang SJ, Lin G, Redfield MM, Borlaug BA. Right heart dysfunction in heart failure with preserved ejection fraction. Eur Heart J 2014;35: 3452-3462.
8. Pellegrini P, Rossi A, Pasotti M, Raineri C, Cicoira M, Bonapace S, Dini FL, Temporelli PL, Vassanelli C, Vanderpool R, et al. Prognostic relevance of pulmonary arterial compliance in patients with chronic heart failure. Chest 2014;145: 1064-1070.
9. GalièN, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, et al.; ESC Committee for Practice Guidelines (CPG). Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009;30: 2493-2537.
10. Redfield MM, Chen HH, Borlaug BA, Semigran MJ, Lee KL, Lewis G, LeWinter MM, Rouleau JL, Bull DA, Mann DL, et al.; RELAX Trial. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. JAMA 2013;309: 1268-1277.
11. Bonderman D, Ghio S, Felix SB, Ghofrani HA, Michelakis E, Mitrovic V, Oudiz RJ, Boateng F, Scalise AV, Roessig L, et al.; Left Ventricular Systolic Dysfunction Associated With Pulmonary Hypertension Riociguat Trial (LEPHT) Study Group. Riociguat for patients with pulmonary hypertension caused by systolic left ventricular dysfunction: a phase IIb double-blind, randomized, placebocontrolled, dose-ranging hemodynamic study. Circulation 2013;128: 502-511.
12. Bonderman D, Pretsch I, Steringer-Mascherbauer R, Jansa P, Rosenkranz S, Tufaro C, Bojic A, Lam CS, Frey R, Ochan Kilama M, et al. Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, singledose study. Chest 2014;146: 1274-1285.
13. Gerges C, Gerges M, Lang MB, Zhang Y, Jakowitsch J, Probst P, Maurer G, Lang IM. Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in "out-of-proportion" pulmonary hypertension. Chest 2013;143: 758-766.
14. Gerges M, Gerges C, Pistritto A-M, Lang MB, Jakowitsch J, Binder T, Lang IM. Epidemiology of combined pre- and post-capillary pulmonary hypertension in patients with heart failure. Eur Heart J 2014;35(Abstract Suppl): 175-176.
15. Gerges M, Gerges C, Pistritto A-M, Lang MB, Trip P, Jakowitsch J, Binder T, Lang IM. Combined pre-and post-capillary pulmonary hypertension in patients with heart failure: epidemiology and right ventricular function. Presented at Symposium on Cardiac and Vascular Stiffness, September 26-27, 2014, Graz, Austria.
16. Gerges M, Gerges C, Pistritto A-M, Lang MB, Trip P, Jakowitsch J, Binder T, Lang IM. PH due to left heart disease (PH-LHD): epidemiology and right ventricular function [abstract]. Am J Respir Crit Care Med 2015;191: A4850.
17. Gerges M, Gerges C, Pistritto A-M, Lang MB, Trip P, Jakowitsch J, Binder T, Lang IM. Pulmonary hypertension in chronic heart failure: epidemiology, right ventricular function and survival. Presented at the Annual Meeting of the Austrian Society of Cardiology 2015. May 27-30, 2015, Salzburg, Austria. Abstract 6.
18. LeVarge BL, Pomerantsev E, Channick RN. Reliance on end-expiratory wedge pressure leads to misclassification of pulmonary hypertension. Eur Respir J 2014;44: 425-434.
19. Kovacs G, Avian A, Pienn M, Naeije R, Olschewski H. Reading pulmonary vascular pressure tracings. How to handle the problems of zero leveling and respiratory swings. Am J Respir Crit Care Med 2014;190: 252-257.
20. Kovacs G, Avian A, Olschewski A, Olschewski H. Zero reference level for right heart catheterisation. Eur Respir J 2013;42: 1586-1594.
21. Harvey RM, Enson Y, Ferrer MI. A reconsideration of the origins of pulmonary hypertension. Chest 1971;59: 82-94.
22. Naeije R, Vachiery JL, Yerly P, Vanderpool R. The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease. Eur Respir J 2013;41: 217-223.
23. Lankhaar JW, Westerhof N, Faes TJ, Marques KM, Marcus JT, Postmus PE, Vonk-Noordegraaf A. Quantification of right ventricular afterload in patients with and without pulmonary hypertension. Am J Physiol Heart Circ Physiol 2006;291: H1731-H1737.
24. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, et al.; ESC Committee for Practice Guidelines. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012;33: 1787-1847.
25. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, et al.; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013;62: e147-e239.
26. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015; 28: 1-39.e14.
27. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16: 31-41.
28. Sunagawa K, Yamada A, Senda Y, Kikuchi Y, Nakamura M, Shibahara T, Nose Y. Estimation of the hydromotive source pressure from ejecting beats of the left ventricle. IEEE Trans Biomed Eng 1980;27: 299-305.
29. Takeuchi M, Igarashi Y, Tomimoto S, Odake M, Hayashi T, Tsukamoto T, Hata K, Takaoka H, Fukuzaki H. Single-beat estimation of the slope of the end-systolic pressure-volume relation in the human left ventricle. Circulation 1991;83: 202-212.
30. Brimioulle S, Wauthy P, Ewalenko P, Rondelet B, Vermeulen F, Kerbaul F, Naeije R. Single-beat estimation of right ventricular end-systolic pressure-volume relationship. Am J Physiol Heart Circ Physiol 2003;284: H1625-H1630.
31. Trip P, Kind T, van de Veerdonk MC, Marcus JT, de Man FS, Westerhof N, Vonk-Noordegraaf A. Accurate assessment of loadindependent right ventricular systolic function in patients with pulmonary hypertension. J Heart Lung Transplant 2013; 32: 50-55.
32. Askenazi J, Parisi AF, Cohn PF, Freedman WB, Braunwald E. Value of the QRS complex in assessing left ventricular ejection fraction. Am J Cardiol 1978;41: 494-499.
33. Guazzi M, Bandera F, Pelissero G, Castelvecchio S, Menicanti L, Ghio S, Temporelli PL, Arena R. Tricuspid annular plane systolic excursion and pulmonary arterial systolic pressure relationship in heart failure: an index of right ventricular contractile function and prognosis. Am J Physiol Heart Circ Physiol 2013;305: H1373-1381.
34. Tedford RJ, Beaty CA, Mathai SC, Kolb TM, Damico R, Hassoun PM, Leary PJ, Kass DA, Shah AS. Prognostic value of the pre-transplant diastolic pulmonary artery pressure-to-pulmonary capillary wedge pressure gradient in cardiac transplant recipients with pulmonary hypertension. J Heart Lung Transplant 2014;33: 289-297.
35. Gerges C, Gerges M, Lang IM. Characterization of pulmonary hypertension in heart failure using the diastolic pressure gradient: the conundrum of high and low diastolic pulmonary gradient. JACC Heart Fail 2015;3: 424-425.
36. Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, Baughman KL, Kasper EK. Underlying causes and longterm survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000;342: 1077-1084.
37. Tedford RJ, Hassoun PM, Mathai SC, Girgis RE, Russell SD, Thiemann DR, Cingolani OH, Mudd JO, Borlaug BA, Redfield MM, et al. Pulmonary capillary wedge pressure augments right ventricular pulsatile loading. Circulation 2012;125: 289-297.
38. Trip P, Rain S, Handoko ML, van der Bruggen C, Bogaard HJ, Marcus JT, Boonstra A, Westerhof N, Vonk-Noordegraaf A, de Man FS. Clinical relevance of right ventricular diastolic stiffness in pulmonary hypertension. Eur Respir J 2015;45: 1603-1612.
39. Tedford RJ, Mudd JO, Girgis RE, Mathai SC, Zaiman AL, Housten- Harris T, Boyce D, Kelemen BW, Bacher AC, Shah AA, et al. Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension. Circ Heart Fail 2013;6: 953-963.
40. Guazzi M, Vicenzi M, Arena R, Guazzi MD. Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study. Circulation 2011;124: 164-174.